Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in elderly patients with metastatic renal cell carcinoma (SERCC study)
2010-019726-14Phase 2Terminated
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sorafenib in clear cell renal cell carcinoma (ccRCC), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Incidence of HFSR (all grades). Started Apr 2010; status: terminated.
02
Drugs
sorafenib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on 2010-019726-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019726-14.